Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host
- PMID: 16129338
- DOI: 10.1016/j.tvjl.2004.05.009
Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host
Abstract
Marek's disease (MD) is a highly contagious lymphoproliferative disease of poultry caused by the oncogenic herpesvirus designated Marek's disease virus (MDV). MD has a worldwide distribution and is thought to cause an annual loss over 1 bn US dollars to the poultry industry. Originally described as a paralytic disease, today MD is mostly manifested as an acute disease with tumours in multiple visceral organs. MD is controlled essentially by the widespread use of live vaccines administered either in ovo into 18-day-old embryos or into chicks immediately after they hatch. In spite of the success of the vaccines in reducing the losses from the disease in the last 30 years, MDV strains have shown continuous evolution in virulence acquiring the ability to overcome the immune responses induced by the vaccines. During this period, different generations of MD vaccines have been introduced to protect birds from the increasingly virulent MDV strains. However, the virus has countered each new vaccine with ever more virulent strains. This continuous race between the virus and the host is making the control of this poultry health problem a major challenge for the future.
Comment in
-
Marek's disease: the continuing struggle between pathogen and host.Vet J. 2005 Sep;170(2):149-50. doi: 10.1016/j.tvjl.2004.10.005. Epub 2004 Nov 21. Vet J. 2005. PMID: 16129335 No abstract available.
Similar articles
-
Marek's disease: the continuing struggle between pathogen and host.Vet J. 2005 Sep;170(2):149-50. doi: 10.1016/j.tvjl.2004.10.005. Epub 2004 Nov 21. Vet J. 2005. PMID: 16129335 No abstract available.
-
Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?Expert Rev Vaccines. 2005 Feb;4(1):77-88. doi: 10.1586/14760584.4.1.77. Expert Rev Vaccines. 2005. PMID: 15757475 Review.
-
Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.Vet Microbiol. 2004 Sep 8;102(3-4):147-67. doi: 10.1016/j.vetmic.2004.06.007. Vet Microbiol. 2004. PMID: 15327791
-
Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.Avian Pathol. 2004 Apr;33(2):190-5. doi: 10.1080/03079450310001652103. Avian Pathol. 2004. PMID: 15276986 Clinical Trial.
-
Marek's disease: an update on oncogenic mechanisms and control.Res Vet Sci. 2000 Aug;69(1):17-23. doi: 10.1053/rvsc.2000.0396. Res Vet Sci. 2000. PMID: 10924389 Review.
Cited by
-
Unraveling the evolutionary origin of the complex Nuclear Receptor Element (cNRE), a cis-regulatory module required for preferential expression in the atrial chamber.Commun Biol. 2024 Apr 4;7(1):371. doi: 10.1038/s42003-024-05972-6. Commun Biol. 2024. PMID: 38575811 Free PMC article.
-
Markets as drivers of selection for highly virulent poultry pathogens.Nat Commun. 2024 Jan 19;15(1):605. doi: 10.1038/s41467-024-44777-3. Nat Commun. 2024. PMID: 38242897 Free PMC article.
-
The future of evolutionary medicine: sparking innovation in biomedicine and public health.Front Sci. 2023;1:997136. doi: 10.3389/fsci.2023.997136. Epub 2023 Feb 28. Front Sci. 2023. PMID: 37869257 Free PMC article.
-
Differences in Pathogenicity and Vaccine Resistance Discovered between Two Epidemic Strains of Marek's Disease Virus in China.Viruses. 2023 Apr 11;15(4):945. doi: 10.3390/v15040945. Viruses. 2023. PMID: 37112925 Free PMC article.
-
Role of T Cells in Vaccine-Mediated Immunity against Marek's Disease.Viruses. 2023 Feb 28;15(3):648. doi: 10.3390/v15030648. Viruses. 2023. PMID: 36992357 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
